Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma

High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been standardized. We herein describe the efficacy of a combination of ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Mineko, Fujimaki, Takamitsu, Asano, Shuichiro, Nakaguchi, Hiroshi, Yamada, Shoko M., Hoya, Katsumi, Yamazaki, Kazuto, Ishida, Yasuo, Matsuno, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220260/
https://www.ncbi.nlm.nih.gov/pubmed/22028172
http://dx.doi.org/10.3349/ymj.2011.52.6.1031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220260/
https://www.ncbi.nlm.nih.gov/pubmed/22028172
http://dx.doi.org/10.3349/ymj.2011.52.6.1031

Ejemplares similares